Boyd Watterson Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$389 Sell
65
-28
-30% -$211 ﹤0.01% 381
2025
Q4
$667 Hold
93
﹤0.01% 408
2025
Q3
$993 Sell
93
-5
-5% -$49 ﹤0.01% 401
2025
Q2
$949 Hold
98
﹤0.01% 406
2025
Q1
$1.46K Hold
98
﹤0.01% 395
2024
Q4
$1.46K Hold
98
﹤0.01% 406
2024
Q3
$1.88K Sell
98
-37
-27% -$767 ﹤0.01% 397
2024
Q2
$2.79K Sell
135
-6,500
-98% -$129K ﹤0.01% 381
2024
Q1
$125K Hold
6,635
0.04% 137
2023
Q4
$95.7K Hold
6,635
0.04% 150
2023
Q3
$115K Sell
6,635
-15
-0.2% -$313 0.05% 138
2023
Q2
$138K Sell
6,650
-2
-0% -$43 0.06% 134
2023
Q1
$156K Sell
6,652
-10
-0.2% -$269 0.06% 136
2022
Q4
$186K Buy
+6,662
New +$170K 0.08% 131
2022
Q3
Sell
-7,771
Closed -$262K 134
2022
Q2
$262K Sell
7,771
-51
-0.7% -$1.79K 0.11% 118
2022
Q1
$273K Sell
7,822
-334
-4% -$11.4K 0.1% 128
2021
Q4
$248K Sell
8,156
-62
-0.8% -$2.02K 0.08% 142
2021
Q3
$269K Buy
+8,218
New +$263K 0.1% 128

Other funds holding OGN

Boyd Watterson Asset Management's OGN Position: Q1 2026 in Review

Boyd Watterson Asset Management reduced its Organon & Co (OGN) stake by 30% in Q1 2026, selling an estimated $211 and leaving 65 shares worth $389. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Boyd Watterson Asset Management first reported a position in OGN in Q3 2021 and has held it in 18 quarters since. The position peaked at $273K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Boyd Watterson Asset Management held 65 shares of Organon & Co worth $389 as of Q1 2026.
  • Boyd Watterson Asset Management sold 28 Organon & Co shares in Q1 2026, an estimated $211.
  • Organon & Co made up ﹤0.01% of Boyd Watterson Asset Management's portfolio in Q1 2026, its #381 holding.
  • Boyd Watterson Asset Management first reported a position in Organon & Co in Q3 2021 and has held it in 18 quarters since.
  • Boyd Watterson Asset Management's Organon & Co position peaked at $273K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.